Buscar
60 Degrees Pharmaceuticals Inc
SXTPWAñadir a la lista de seguimiento
0.030USD
-0.000-0.67%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
0.00Cap. mercado
--P/E TTM
Más Datos de 60 Degrees Pharmaceuticals Inc Compañía
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years of age and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
Información de 60 Degrees Pharmaceuticals Inc
Símbolo de cotizaciónSXTPW
Nombre de la empresa60 Degrees Pharmaceuticals Inc
Fecha de salida a bolsaJul 12, 2023
Director ejecutivoDr. Ll S. Dow, Ph.D.
Número de empleados- -
Tipo de seguridadCompany Warrant
Fin del año fiscal- -
Dirección1025 Connecticut Avenue Nw
CiudadWASHINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal20036
Teléfono12023275422
Sitio Webhttps://60degreespharma.com/
Símbolo de cotizaciónSXTPW
Fecha de salida a bolsaJul 12, 2023
Director ejecutivoDr. Ll S. Dow, Ph.D.
Ejecutivos de 60 Degrees Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
--
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
--
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
--
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
--
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
--
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
--
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de 60 Degrees Pharmaceuticals Inc?
Los cinco principales accionistas de 60 Degrees Pharmaceuticals Inc son: Dr. Geoffrey S. Dow, Ph.D.